• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感对老年小鼠肺部感染期间肺炎球菌疫苗效力的影响。

Impact of Influenza on Pneumococcal Vaccine Effectiveness during Infection in Aged Murine Lung.

作者信息

Jirru Ermias, Lee Stefi, Harris Rebecca, Yang Jianjun, Cho Soo Jung, Stout-Delgado Heather

机构信息

Weill Cornell Medicine, Division of Pulmonary and Critical Care, New York, NY 10022, USA.

出版信息

Vaccines (Basel). 2020 Jun 11;8(2):298. doi: 10.3390/vaccines8020298.

DOI:10.3390/vaccines8020298
PMID:32545261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7349919/
Abstract

Changes in innate and adaptive immune responses caused by viral imprinting can have a significant direct or indirect influence on secondary infections and vaccine responses. The purpose of our current study was to investigate the role of immune imprinting by influenza on pneumococcal vaccine effectiveness during infection in the aged murine lung. Aged adult (18 months) mice were vaccinated with the pneumococcal polyvalent vaccine Pneumovax (5 mg/mouse). Fourteen days post vaccination, mice were instilled with PBS or influenza A/PR8/34 virus (3.5 × 10 PFU). Control and influenza-infected mice were instilled with PBS or (1 × 10 CFU, ATCC 6303) on day 7 of infection and antibacterial immune responses were assessed in the lung. Our results illustrate that, in response to a primary influenza infection, there was diminished bacterial clearance and heightened production of pro-inflammatory cytokines, such as IL6 and IL1β. Vaccination with Pneumovax decreased pro-inflammatory cytokine production by modulating NFҡB expression; however, these responses were significantly diminished after influenza infection. Taken together, the data in our current study illustrate that immune imprinting by influenza diminishes pneumococcal vaccine efficacy and, thereby, may contribute to increased susceptibility of older persons to a secondary infection with .

摘要

病毒印记引起的先天性和适应性免疫反应变化可对继发感染和疫苗反应产生重大的直接或间接影响。我们当前研究的目的是调查流感免疫印记在老年小鼠肺部感染期间对肺炎球菌疫苗效力的作用。成年老龄(18个月)小鼠接种肺炎球菌多价疫苗Pneumovax(5毫克/小鼠)。接种疫苗14天后,给小鼠滴注磷酸盐缓冲盐水(PBS)或甲型流感病毒A/PR8/34(3.5×10个噬斑形成单位)。在感染第7天,给对照小鼠和感染流感的小鼠滴注PBS或肺炎链球菌(1×10个菌落形成单位,美国典型培养物保藏中心6303),并评估肺部的抗菌免疫反应。我们的结果表明,作为对原发性流感感染的反应,细菌清除减少,促炎细胞因子如白细胞介素6(IL6)和白细胞介素1β(IL1β)的产生增加。接种Pneumovax疫苗通过调节核因子κB(NFҡB)表达降低促炎细胞因子的产生;然而,流感感染后这些反应显著减弱。综上所述,我们当前研究中的数据表明,流感免疫印记会降低肺炎球菌疫苗效力,从而可能导致老年人易发生继发感染。

相似文献

1
Impact of Influenza on Pneumococcal Vaccine Effectiveness during Infection in Aged Murine Lung.流感对老年小鼠肺部感染期间肺炎球菌疫苗效力的影响。
Vaccines (Basel). 2020 Jun 11;8(2):298. doi: 10.3390/vaccines8020298.
2
Protective efficacy of mucosal and subcutaneous immunization with DnaJ-ΔA146Ply against influenza and Streptococcus pneumoniae co-infection in mice.用DnaJ-ΔA146Ply进行黏膜和皮下免疫对小鼠流感和肺炎链球菌共感染的保护效力
Microbes Infect. 2021 Sep-Oct;23(8):104813. doi: 10.1016/j.micinf.2021.104813. Epub 2021 Mar 31.
3
Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.抗菌疫苗对流感感染后3型肺炎球菌继发性肺炎的疗效有限。
J Infect Dis. 2015 Aug 1;212(3):445-52. doi: 10.1093/infdis/jiv066. Epub 2015 Feb 3.
4
Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.静脉滴注帕拉米韦能够抑制病毒复制,并且在甲型 H1N1pdm09 流感病毒和肺炎链球菌引起的细菌性合并感染的小鼠模型中,能够促进细菌清除并降低死亡率。
Antiviral Res. 2015 May;117:52-9. doi: 10.1016/j.antiviral.2015.02.012. Epub 2015 Mar 6.
5
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.白细胞介素-10是流感感染后对肺炎球菌肺炎易感性增强的重要介质。
J Immunol. 2004 Jun 15;172(12):7603-9. doi: 10.4049/jimmunol.172.12.7603.
6
Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Challenge during Influenza A Infection.评估肺炎球菌表面蛋白A作为甲型流感感染期间二次攻击的疫苗抗原。
Vaccines (Basel). 2019 Oct 11;7(4):146. doi: 10.3390/vaccines7040146.
7
Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.多价23表位多糖肺炎疫苗通过适应性菌株效应机制诱导有效保护,这在受到两种不同肺炎链球菌菌株攻击的小鼠中不同的细胞因子反应得到了证明。
Eur Cytokine Netw. 2007 Mar;18(1):23-30. doi: 10.1684/ecn.2007.0082. Epub 2007 Mar 30.
8
Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.当与灭活流感疫苗联合使用时,对一种血清型非依赖性肺炎球菌疫苗的增强保护反应。
Clin Sci (Lond). 2017 Jan 1;131(2):169-180. doi: 10.1042/CS20160475. Epub 2016 Nov 24.
9
Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.过敏性气道疾病可预防甲型流感病毒-肺炎链球菌合并感染的致死协同作用。
mBio. 2019 Jul 2;10(4):e01335-19. doi: 10.1128/mBio.01335-19.
10
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.流感病毒感染期间气道上皮细胞的去唾液酸化通过半乳糖凝集素结合增强肺炎球菌黏附。
Mol Immunol. 2015 May;65(1):1-16. doi: 10.1016/j.molimm.2014.12.010. Epub 2015 Jan 16.

引用本文的文献

1
Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection.人源单克隆抗体可预防病毒介导的肺炎链球菌再感染。
Front Immunol. 2024 Jun 12;15:1364622. doi: 10.3389/fimmu.2024.1364622. eCollection 2024.
2
Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies.老年人群疫苗研究进展:从免疫衰老的影响到接种策略
NPJ Vaccines. 2024 Apr 10;9(1):77. doi: 10.1038/s41541-024-00874-4.
3
Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.

本文引用的文献

1
Autologous Splenocyte Reinfusion Improves Antibody-Mediated Immune Response to the 23-Valent Pneumococcal Polysaccharide-Based Vaccine in Splenectomized Mice.自体脾细胞输注可改善脾切除小鼠对 23 价肺炎球菌多糖疫苗的抗体介导免疫应答。
Biomolecules. 2020 May 1;10(5):704. doi: 10.3390/biom10050704.
2
Disruption of the and Genes Attenuates Virulence: Towards the Development of a Live Attenuated Vaccine Candidate.[具体基因名称]和[具体基因名称]基因的破坏减弱了[病毒名称]的毒力:迈向减毒活疫苗候选株的开发。 (你提供的原文中部分基因名称等信息缺失,以上是根据格式要求给出的大致翻译,实际需补充完整准确信息)
Vaccines (Basel). 2020 Apr 15;8(2):187. doi: 10.3390/vaccines8020187.
3
记忆性 Th17 细胞介导的流感感染后对致死性二次肺炎链球菌肺炎的保护作用。
mBio. 2023 Aug 31;14(4):e0051923. doi: 10.1128/mbio.00519-23. Epub 2023 May 24.
Immune Imprinting in the Influenza Ferret Model.
流感雪貂模型中的免疫印记
Vaccines (Basel). 2020 Apr 8;8(2):173. doi: 10.3390/vaccines8020173.
4
Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.肺炎链球菌结合疫苗调节流感后继发肺炎链球菌引起的巨噬细胞介导的固有免疫。
Microbes Infect. 2020 Sep;22(8):312-321. doi: 10.1016/j.micinf.2019.12.005. Epub 2020 Jan 17.
5
Influenza imprinting in childhood and the influence on vaccine response later in life.儿童期的流感印记及其对生命后期疫苗反应的影响。
Euro Surveill. 2019 Nov;24(48). doi: 10.2807/1560-7917.ES.2019.24.48.1900720.
6
Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Challenge during Influenza A Infection.评估肺炎球菌表面蛋白A作为甲型流感感染期间二次攻击的疫苗抗原。
Vaccines (Basel). 2019 Oct 11;7(4):146. doi: 10.3390/vaccines7040146.
7
Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus.人类 CD4 T 细胞对流感病毒反应的印迹与编辑。
Front Immunol. 2019 May 7;10:932. doi: 10.3389/fimmu.2019.00932. eCollection 2019.
8
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma.采用多种抗原工程化的树突状细胞疫苗联合或不联合 IFNα 以促进黑色素瘤的抗肿瘤免疫。
J Immunother Cancer. 2019 Apr 24;7(1):113. doi: 10.1186/s40425-019-0552-x.
9
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge.一种新型多抗原肺炎球菌疫苗可预防致死性挑战。
Infect Immun. 2019 Feb 21;87(3). doi: 10.1128/IAI.00846-18. Print 2019 Mar.
10
Airway Epithelial Differentiation and Mucociliary Clearance.气道上皮细胞分化和黏液纤毛清除功能。
Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S143-S148. doi: 10.1513/AnnalsATS.201802-128AW.